Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies
Incyte Corporation
Incyte Corporation
Incyte Corporation
Bayer
BerGenBio ASA
Novo Nordisk A/S
Karyopharm Therapeutics Inc
Celgene
Gilead Sciences
Stanford University
Icahn School of Medicine at Mount Sinai
Stanford University
University of South Florida
INSYS Therapeutics Inc